About ProteinSimple
ProteinSimple is a company based in San Jose (United States) founded in 2004 was acquired by Bio-Techne in June 2014.. ProteinSimple has raised $114.29 million across 8 funding rounds from investors including Royal Bank of Canada, Bio-Techne and Wellcome. ProteinSimple has completed 4 acquisitions, including Alpha Innotech, Brightwell Tech and Convergent Bioscience. ProteinSimple operates in a competitive market with competitors including Somalogic, Cyrus Biotechnology, Vividion Therapeutics, Nautilus Biotechnology and Amunix, among others.
- Headquarter San Jose, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bio-Techne Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$114.29 M (USD)
in 8 rounds
-
Latest Funding Round
$13 M (USD), Series F
May 11, 2011
-
Investors
Royal Bank of Canada
& 10 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Alpha Innotech
& 3 more
-
Acquired by
Bio-Techne
(Jun 17, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Software Development Team
92 people
Sales and Marketing
76 people
Leadership Team
40 people
Product Management Team
35 people
Senior Team
31 people
Finance and Accounting
20 people
Human Resources and Administration
18 people
Advanced Team
13 people
Unlock access to complete
Funding Insights of ProteinSimple
ProteinSimple has successfully raised a total of $114.29M across 8 strategic funding rounds. The most recent funding activity was a Series F round of $13 million completed in May 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series F — $13.0M
-
First Round
First Round
(01 Nov 2006)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2011 | Amount | Series F - ProteinSimple | Valuation |
investors |
|
| Oct, 2010 | Amount | Series F - ProteinSimple | Valuation |
investors |
|
| Dec, 2009 | Amount | Series D - ProteinSimple | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ProteinSimple
ProteinSimple has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Royal Bank of Canada, Bio-Techne and Wellcome. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life science & tech focused VC firm investing in the US
|
Founded Year | Domain | Location | |
|
Early-stage healthcare startups are supported with venture capital.
|
Founded Year | Domain | Location | |
|
Investments in early and late-stage US companies are made.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ProteinSimple
ProteinSimple has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Alpha Innotech, Brightwell Tech and Convergent Bioscience. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Protein fractionation instruments and software for mass spectrometry are developed.
|
2002 | ||||
|
Tech solutions are explored via a dedicated blog platform.
|
2001 | ||||
|
Protein characterization equipment is supplied for pharmaceutical and biotech sectors.
|
1995 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - ProteinSimple
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Proteinsimple Comparisons
Competitors of ProteinSimple
ProteinSimple operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Somalogic, Cyrus Biotechnology, Vividion Therapeutics, Nautilus Biotechnology and Amunix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Protein-based assays are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Cloud-based protein-modeling software is developed for drug discovery.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
A proteomics platform is developed for analyzing the human proteome.
|
|
| domain | founded_year | HQ Location |
Peptide-based therapeutics are developed for cancers and immune disorders.
|
|
| domain | founded_year | HQ Location |
Proteomics platform developed for early cancer and neurological disease detection.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Proteinsimple
Frequently Asked Questions about ProteinSimple
When was ProteinSimple founded?
ProteinSimple was founded in 2004 and raised its 1st funding round 2 years after it was founded.
Where is ProteinSimple located?
ProteinSimple is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Is ProteinSimple a funded company?
ProteinSimple is a funded company, having raised a total of $114.29M across 8 funding rounds to date. The company's 1st funding round was a Series D of $9.25M, raised on Nov 01, 2006.
What does ProteinSimple do?
Provider tools to help researchers with protein analysis. It offers Simple Plex Assays, multi-analyte immunoassays for biomarker research, Micro-Flow Imaging (MFI), a solution for aggregate and particle analysis, as well as monitoring and characterizing aggregates during the formulation development process, and AlphaImager gel documentation systems that provide imaging for a range of UV fluorescent and colorimetric applications. The company also provides Simple Western Assays that provide quantitative protein characterization and protein analysis in precious samples and an iCE System that measures protein purity, charges heterogeneity protein analysis, evaluates formulation development, and screens cell lines.
Who are the top competitors of ProteinSimple?
ProteinSimple's top competitors include Somalogic, Vividion Therapeutics and Cyrus Biotechnology.
How many acquisitions has ProteinSimple made?
ProteinSimple has made 4 acquisitions, including Alpha Innotech, Brightwell Tech, and Convergent Bioscience.
Who are ProteinSimple's investors?
ProteinSimple has 11 investors. Key investors include Royal Bank of Canada, Bio-Techne, Wellcome, Wellcome, and Domain Associates.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.